Levi, M.; Goshen-Lago, T.; Yerushalmi, R.; Granot, T.; Stemmer, S.M.; Shalgi, R.; Ben-Aharon, I.
Anti-HER2/neu Antibody Reduces Chemotherapy-Induced Ovarian Toxicity—From Bench to Bedside. Biomedicines 2020, 8, 577.
https://doi.org/10.3390/biomedicines8120577
AMA Style
Levi M, Goshen-Lago T, Yerushalmi R, Granot T, Stemmer SM, Shalgi R, Ben-Aharon I.
Anti-HER2/neu Antibody Reduces Chemotherapy-Induced Ovarian Toxicity—From Bench to Bedside. Biomedicines. 2020; 8(12):577.
https://doi.org/10.3390/biomedicines8120577
Chicago/Turabian Style
Levi, Mattan, Tal Goshen-Lago, Rinat Yerushalmi, Tal Granot, Salomon M. Stemmer, Ruth Shalgi, and Irit Ben-Aharon.
2020. "Anti-HER2/neu Antibody Reduces Chemotherapy-Induced Ovarian Toxicity—From Bench to Bedside" Biomedicines 8, no. 12: 577.
https://doi.org/10.3390/biomedicines8120577
APA Style
Levi, M., Goshen-Lago, T., Yerushalmi, R., Granot, T., Stemmer, S. M., Shalgi, R., & Ben-Aharon, I.
(2020). Anti-HER2/neu Antibody Reduces Chemotherapy-Induced Ovarian Toxicity—From Bench to Bedside. Biomedicines, 8(12), 577.
https://doi.org/10.3390/biomedicines8120577